HK1061244A1 - Tricyclic derivatives of indole with antiangiogenic activity - Google Patents
Tricyclic derivatives of indole with antiangiogenic activityInfo
- Publication number
- HK1061244A1 HK1061244A1 HK04104343A HK04104343A HK1061244A1 HK 1061244 A1 HK1061244 A1 HK 1061244A1 HK 04104343 A HK04104343 A HK 04104343A HK 04104343 A HK04104343 A HK 04104343A HK 1061244 A1 HK1061244 A1 HK 1061244A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- indole
- antiangiogenic activity
- tricyclic derivatives
- tricyclic
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2000RM000570A IT1317926B1 (it) | 2000-11-03 | 2000-11-03 | Derivati triciclici dell'indolo ad attivita' antiangiogenica. |
PCT/IT2001/000526 WO2002036597A1 (fr) | 2000-11-03 | 2001-10-16 | Derives tricycliques de l'indole a activite anti-angiogenique |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1061244A1 true HK1061244A1 (en) | 2004-09-10 |
Family
ID=11454976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04104343A HK1061244A1 (en) | 2000-11-03 | 2004-06-16 | Tricyclic derivatives of indole with antiangiogenic activity |
Country Status (20)
Country | Link |
---|---|
US (2) | US6887892B2 (fr) |
EP (1) | EP1343789B1 (fr) |
JP (1) | JP2004513130A (fr) |
KR (1) | KR20030042030A (fr) |
CN (1) | CN1247589C (fr) |
AT (1) | ATE302780T1 (fr) |
AU (1) | AU1518602A (fr) |
BR (1) | BR0115119A (fr) |
CA (1) | CA2427568A1 (fr) |
CZ (1) | CZ297299B6 (fr) |
DE (1) | DE60112966T2 (fr) |
DK (1) | DK1343789T3 (fr) |
ES (1) | ES2247182T3 (fr) |
HK (1) | HK1061244A1 (fr) |
HU (1) | HUP0400546A3 (fr) |
IT (1) | IT1317926B1 (fr) |
MX (1) | MXPA03003798A (fr) |
PL (1) | PL364908A1 (fr) |
SK (1) | SK5342003A3 (fr) |
WO (1) | WO2002036597A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6849656B1 (en) | 1999-09-17 | 2005-02-01 | Baylor University | Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents |
US7528165B2 (en) | 2001-12-13 | 2009-05-05 | National Health Research Institutes | Indole compounds |
US7632955B2 (en) | 2001-12-13 | 2009-12-15 | National Health Research Institutes | Indole compounds |
US6800655B2 (en) | 2002-08-20 | 2004-10-05 | Sri International | Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents |
US7456289B2 (en) | 2004-12-31 | 2008-11-25 | National Health Research Institutes | Anti-tumor compounds |
JP2008530229A (ja) * | 2005-02-17 | 2008-08-07 | ワイス | シクロアルキル縮合インドール、ベンゾチオフェン、ベンゾフランおよびインデン誘導体 |
ATE481396T1 (de) * | 2006-04-25 | 2010-10-15 | Merck Patent Gmbh | Hexahydro-dibenzofuranderivate |
FR2928645A1 (fr) | 2008-03-14 | 2009-09-18 | Sanofi Aventis Sa | Nouveaux derives de carbazole inhibiteurs d'hsp90, compositions les contenant et utilisation |
WO2014041125A1 (fr) * | 2012-09-13 | 2014-03-20 | Baden-Württemberg Stiftung Gmbh | Inhibiteurs spécifiques de la protéine p21 comme agents thérapeutiques |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5100891A (en) | 1991-01-18 | 1992-03-31 | Hoechst-Roussel Pharmaceuticals Inc. | Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds |
US5350762A (en) | 1993-03-08 | 1994-09-27 | Hoechst-Roussel Pharmaceuticals Incorporated | Tetrahydrocyclopent[B]indole methanamines and related compounds |
-
2000
- 2000-11-03 IT IT2000RM000570A patent/IT1317926B1/it active
-
2001
- 2001-10-16 WO PCT/IT2001/000526 patent/WO2002036597A1/fr active IP Right Grant
- 2001-10-16 SK SK534-2003A patent/SK5342003A3/sk not_active Application Discontinuation
- 2001-10-16 PL PL01364908A patent/PL364908A1/xx unknown
- 2001-10-16 DE DE60112966T patent/DE60112966T2/de not_active Expired - Fee Related
- 2001-10-16 JP JP2002539355A patent/JP2004513130A/ja active Pending
- 2001-10-16 CA CA002427568A patent/CA2427568A1/fr not_active Abandoned
- 2001-10-16 BR BR0115119-3A patent/BR0115119A/pt not_active IP Right Cessation
- 2001-10-16 EP EP01983768A patent/EP1343789B1/fr not_active Expired - Lifetime
- 2001-10-16 AT AT01983768T patent/ATE302780T1/de not_active IP Right Cessation
- 2001-10-16 KR KR10-2003-7005651A patent/KR20030042030A/ko not_active Application Discontinuation
- 2001-10-16 DK DK01983768T patent/DK1343789T3/da active
- 2001-10-16 HU HU0400546A patent/HUP0400546A3/hu unknown
- 2001-10-16 US US10/415,896 patent/US6887892B2/en not_active Expired - Fee Related
- 2001-10-16 CN CNB018181996A patent/CN1247589C/zh not_active Expired - Fee Related
- 2001-10-16 CZ CZ20031042A patent/CZ297299B6/cs not_active IP Right Cessation
- 2001-10-16 MX MXPA03003798A patent/MXPA03003798A/es active IP Right Grant
- 2001-10-16 AU AU1518602A patent/AU1518602A/xx not_active Withdrawn
- 2001-10-16 ES ES01983768T patent/ES2247182T3/es not_active Expired - Lifetime
-
2004
- 2004-06-16 HK HK04104343A patent/HK1061244A1/xx not_active IP Right Cessation
-
2005
- 2005-01-11 US US11/032,068 patent/US20050124647A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6887892B2 (en) | 2005-05-03 |
US20040034052A1 (en) | 2004-02-19 |
WO2002036597A1 (fr) | 2002-05-10 |
PL364908A1 (en) | 2004-12-27 |
BR0115119A (pt) | 2003-09-30 |
JP2004513130A (ja) | 2004-04-30 |
ITRM20000570A0 (it) | 2000-11-03 |
HUP0400546A3 (en) | 2007-08-28 |
CZ20031042A3 (cs) | 2003-10-15 |
IT1317926B1 (it) | 2003-07-15 |
ATE302780T1 (de) | 2005-09-15 |
MXPA03003798A (es) | 2004-04-20 |
DE60112966D1 (de) | 2005-09-29 |
CN1471535A (zh) | 2004-01-28 |
EP1343789B1 (fr) | 2005-08-24 |
CZ297299B6 (cs) | 2006-11-15 |
DE60112966T2 (de) | 2006-05-24 |
SK5342003A3 (en) | 2003-10-07 |
ES2247182T3 (es) | 2006-03-01 |
EP1343789A1 (fr) | 2003-09-17 |
DK1343789T3 (da) | 2005-12-27 |
AU1518602A (en) | 2002-05-15 |
CN1247589C (zh) | 2006-03-29 |
CA2427568A1 (fr) | 2002-05-10 |
HUP0400546A2 (hu) | 2004-06-28 |
ITRM20000570A1 (it) | 2002-05-03 |
US20050124647A1 (en) | 2005-06-09 |
KR20030042030A (ko) | 2003-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200003206T2 (tr) | İndol türevleri ve patolojik hücre çoğalmasının neden olduğu habis hastalıklar ve diğer hastalıkların tedavisinde kullanımları. | |
TR200003514T2 (tr) | Pirol ikame edilmiş 2-indolinon protein kinaz inhibitörleri | |
MY125942A (en) | Aminoalkoxy carbazoles for the treatment of cns diseases | |
MY122020A (en) | Use of gabab receptor agonists as reflux inhibitors | |
AU9102198A (en) | Indole-3-carbinol, diindolylmethane and substituted analogs as antiestrogens | |
SG148834A1 (en) | Compounds for the modulation of ppary activity | |
BG105270A (en) | Tetrahydropyridoethers | |
AU1518602A (en) | Tricyclic derivatives of indole with antiangiogenic activity | |
MXPA02009552A (es) | Derivados de imidazopiridina alquilada. | |
TR200001687T2 (tr) | Neopleasyo için N-benzil-3-indenilasetamid türevleri. | |
ATE311389T1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
IL150329A0 (en) | 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity | |
GB2378948B (en) | Novel compounds for modulating cell proliferation | |
HK1055304A1 (en) | Tricyclic imidazopyridines | |
MXPA03003971A (es) | Derivados de indol como inhibidores de pde5. | |
AP2001002045A0 (en) | FKBP inhibitors. | |
ATE243698T1 (de) | 1,2-dihydro-1-oxo-pyrazino(1,2-)indolederivate | |
MXPA04001048A (es) | Imidazopiridinas sustituidas con alquilo, para el tratamiento de trastornos gastrointestinales. | |
IT1314187B1 (it) | Combinazione di differenti composizioni farmaceutiche per iltrattamento del carcinoma mammario e relativo uso | |
EP1894569A3 (fr) | Dérivés de tétracycline pour le traitement du cancer | |
UA36367A (uk) | Кальцію сукцинат, що має кардіотонічну дію | |
AP2001002047A0 (en) | Isoquinoliness as urokinase inhibitors. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20091016 |